Prof. Dr. Ahmet Omma

Comorbidity Profiles in Inflammatory Rheumatic Diseases: An Analytical Perspective

International Journal of Clinical Practice, 2024

DOI 10.1155/2024/3244597 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

Is the visceral adiposity index associated with the presence of cardiovascular risk scores and comorbidity in psoriatic disease?

Ulusal Romatoloji Dergisi, 2024

DOI 10.4274/raed.galenos.2024.83097 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

AB1293 FREQUENCY AND THE EFFECTS OF SPONDYLOARTHRITIS-SPECTRUM DISORDERS ON THE CLINICAL COURSE AND MANAGEMENT OF TAKAYASU ARTERITIS

Annals of the Rheumatic Diseases, 2024

DOI 10.1136/annrheumdis-2024-eular.5448 1 Zitation (OpenAlex) Quelle: OpenAlex

FACIAL ERYTHEMA MAY NOT ALWAYS BE A MANIFESTATION OF THE PRIMARY CONDITION IN CONNECTIVE TISSUE DISEASES: KEEP DEMODEX IN MIND!

2024

DOI 10.22541/au.170668061.18884453/v1 Frei zugänglicher VolltextQuelle: OpenAlex

Effects of intrauterine device use on attack frequency and severity ın woman of reproductive age with familial Mediterranean fever

Archives of Gynecology and Obstetrics, 2024

DOI 10.1007/s00404-024-07413-5 PMID 38478158 Quelle: OpenAlex

Coronavirus Disease 2019 Outcomes in Amyloid A Protein Amyloidosis Secondary to Rheumatic Conditions and Signs of Post- Coronavirus Disease 2019 Proteinuria Progression

European Journal of Rheumatology, 2024

DOI 10.5152/eurjrheum.2024.23050 PMID 38705968 Frei zugänglicher VolltextQuelle: OpenAlex

Assessment of venous disease with different venous disease specific scales in Behçet’s disease patients with deep vein thrombosis

Phlebology The Journal of Venous Disease, 2024

DOI 10.1177/02683555241257868 PMID 38810108 Quelle: OpenAlex

AB1345 COMORBIDITY PROFILES IN INFLAMMATORY RHEUMATIC DISEASES: AN ANALYTICAL PERSPECTIVE

Annals of the Rheumatic Diseases, 2024

DOI 10.1136/annrheumdis-2024-eular.2373 Quelle: OpenAlex

AB1327 VALIDATION OF THE 2022 ACR/EULAR CLASSIFICATION CRITERIA FOR LARGE-VESSEL VASCULITIS; CONFUSION OF CLASSIFICATION BETWEEN CERTAIN AGES REMAINS

Annals of the Rheumatic Diseases, 2024

DOI 10.1136/annrheumdis-2024-eular.5776 Quelle: OpenAlex

AB0724 TOFACITINIB DRUG SURVIVAL MAY BE BETTER IN OBESE TNF INHIBITOR RESISTANT RA PATIENTS

Annals of the Rheumatic Diseases, 2024

DOI 10.1136/annrheumdis-2024-eular.1726 Quelle: OpenAlex

POS0857 REMARKING THE OSTEOPOROSIS IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS (AAV): DATA FROM EASTERN MEDITERRANEAN (TRVAS)

Annals of the Rheumatic Diseases, 2024

DOI 10.1136/annrheumdis-2024-eular.3977 Quelle: OpenAlex

AB1272 MANAGING OF ANCA-ASSOCIATED VASCULITIS: ADHERENCE TO TREATMENT GUIDELINES AND EARLY MODIFICATIONS, ARE WE THERE YET?

Annals of the Rheumatic Diseases, 2024

DOI 10.1136/annrheumdis-2024-eular.5318 Quelle: OpenAlex

AB1328 IS THERE A NEED FOR ROUTINE IMAGING FOLLOW-UP IN PATIENTS WITH TAKAYASU ARTERITIS?

Annals of the Rheumatic Diseases, 2024

DOI 10.1136/annrheumdis-2024-eular.5892 Quelle: OpenAlex

POS0933 THE FREQUENCY OF AORTIC AND MITRAL VALVE INVOLVEMENT IN PATIENTS WITH TAKAYASU ARTERITIS

Annals of the Rheumatic Diseases, 2024

DOI 10.1136/annrheumdis-2024-eular.5914 Quelle: OpenAlex

AB0950 DRUG SURVIVAL AND PREDICTOR FACTORS OF DISCONTINUATION IN AXIAL SPONDYLOARTHRITIS PATIENTS RECEIVING CERTOLIZUMAB AND SECUKINUMAB

Annals of the Rheumatic Diseases, 2024

DOI 10.1136/annrheumdis-2024-eular.3290 Quelle: OpenAlex

Romatolojide Güncel Tedaviler

Akademisyen Kitabevi eBooks, 2024

DOI 10.37609/akya.2736 Frei zugänglicher VolltextQuelle: OpenAlex

Is Regular Vascular Imaging Scheduled Essential in the Follow-Up of Takayasu Arteritis? A Large-Scale Multicenter Cohort Study

Kocaeli Üniversitesi - AVESİS, 2024

Quelle: OpenAlex

Is Regular Vascular Imaging Scheduled Essential in the Follow-Up of Takayasu Arteritis? A Large-Scale Multicenter Cohort Study

Bursa Uludag University - AVESIS, 2024

Quelle: OpenAlex

Biological Treatment May Be an Option as First Steroid-Sparing Agent in a Subgroup of Young Takayasu Arteritis Patients with Prominent Acute Phase Reactants and Constitutional Symptoms

Kocaeli Üniversitesi - AVESİS, 2024

Quelle: OpenAlex

AB0777 PERFORMANCE OF 2022 ACR/EULAR GPA, EGPA AND MPA CLASSIFICATION CRITERIA IN TURKISH VASCULITIS STUDY GROUP PROSPECTIVE COHORT (TRVAS)

Annals of the Rheumatic Diseases, 2023

DOI 10.1136/annrheumdis-2023-eular.5370 Frei zugänglicher VolltextQuelle: OpenAlex

Evaluation of patients with antiphospholipid syndrome subsequently COVID-19 vaccinations: A retrospective cohort study

International journal of rheumatic diseases, 2023

DOI 10.1111/1756-185x.14490 PMID 36371485 8 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: Europe PMC

Semaphorin 3A levels in vascular and nonvascular phenotypes in systemic sclerosis

Laboratory medicine, 2023

DOI 10.1093/labmed/lmad019 PMID 37100766 5 Zitationen (Europe PMC) Quelle: Europe PMC

Effects of sulfasalazine in axial spondyloarthritis on COVID-19 outcomes: real-life data from a single center

Immunopharmacology and immunotoxicology, 2023

DOI 10.1080/08923973.2022.2160729 PMID 36537308 3 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: Europe PMC

Comparative Metabolomic Profiles of Vascular Involvement in Behçet’s Disease

European Journal of Rheumatology, 2023

DOI 10.5152/eurjrheum.2023.23062 PMID 37850605 6 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

Low relapse rate in patients with giant cell arteritis in a multi-centre retrospective Turkish Registry

Clinical and Experimental Rheumatology, 2023

DOI 10.55563/clinexprheumatol/zr7s0g PMID 37976117 6 Zitationen (OpenAlex) Quelle: OpenAlex

Tofacitinib experience in patients with enteropathic arthritis

Immunotherapy, 2023

DOI 10.2217/imt-2022-0110 PMID 37009645 5 Zitationen (OpenAlex) Quelle: OpenAlex

Ustekinumab in Enteropathic Arthritis

Immunotherapy, 2023

DOI 10.2217/imt-2022-0197 PMID 37020400 5 Zitationen (OpenAlex) Quelle: OpenAlex

Non-criteria autoantibodies in antiphospholipid syndrome may be associated with underlying disease activity

Irish Journal of Medical Science (1971 -), 2023

DOI 10.1007/s11845-023-03519-y PMID 37737913 4 Zitationen (OpenAlex) Quelle: OpenAlex

COVID ‐19 disease frequency, risk factors, and re‐infection rates in patients with autoimmune rheumatic disease receiving rituximab

International Journal of Rheumatic Diseases, 2023

DOI 10.1111/1756-185x.14676 PMID 36942871 3 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

Effects of breast milk on Behçet's disease clinical features

TURKISH JOURNAL OF MEDICAL SCIENCES, 2023

DOI 10.55730/1300-0144.5565 PMID 36945965 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

A single-center rheumatology experience of sarcoidosis: observations from 70 patients.

Sarcoidosis vasculitis and diffuse lung diseases, 2023

DOI 10.36141/svdld.v40i3.14063 PMID 37712373 3 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

The Possible Relation of Demodex and Facial Erythema in Connective Tissue Diseases

Iranian Journal of Parasitology, 2023

DOI 10.18502/ijpa.v18i2.13190 PMID 37583642 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

Mortality in psoriatic arthritis patients, changes over time, and the impact of COVID-19: results from a multicenter Psoriatic Arthritis Registry (PsART-ID)

Clinical Rheumatology, 2023

DOI 10.1007/s10067-022-06492-6 PMID 36637636 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

Long-Term Results of Immunogenicity of Booster Vaccination against SARS-CoV-2 (Hybrid COV-RAPEL TR Study) in Turkiye: A Double-Blind, Randomized, Controlled, Multicenter Phase 2 Clinical Study

Vaccines, 2023

DOI 10.3390/vaccines11071234 PMID 37515050 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

Tocilizumab as a first line biologic agent in rheumatoid arthritis patients with inadequate response to disease-modifying anti-rheumatic drugs: real life experience from the TReasure Registry

Clinical and Experimental Rheumatology, 2023

DOI 10.55563/clinexprheumatol/2h6ma1 PMID 37650346 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

AB0756 IDENTIFICATION OF HISTOPATHOLOGIC FINDINGS OF PATIENTS WITH GIANT CELL ARTERITIS: A MULTICENTRE STUDY IN THE ERA OF 2022 ACR/EULAR CLASSIFICATION CRITERIA FOR GCA

Annals of the Rheumatic Diseases, 2023

DOI 10.1136/annrheumdis-2023-eular.1935 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

POS0219 COMPARISON OF METHOTREXATE AND AZATHIOPRINE AS THE FIRST STEROID-SPARING IMMUNOSUPPRESSIVE AGENT IN PATIENTS WITH TAKAYASU'S ARTERITIS

Annals of the Rheumatic Diseases, 2023

DOI 10.1136/annrheumdis-2023-eular.6172 Frei zugänglicher VolltextQuelle: OpenAlex

AB1691 BURDEN OF AFFECTED FACE IN PATIENTS WITH SYSTEMIC SCLEROSIS: A TRANSLATION AND VALIDATION STUDY IN TURKISH

Annals of the Rheumatic Diseases, 2023

DOI 10.1136/annrheumdis-2023-eular.5553 Frei zugänglicher VolltextQuelle: OpenAlex

AB1763-HPR RELIABILITY AND VALIDITY OF THE TURKISH VERSION OF SCLERODERMA SKIN PATIENT-REPORTED OUTCOME IN PATIENTS WITH SYSTEMIC SCLEROSIS

Annals of the Rheumatic Diseases, 2023

DOI 10.1136/annrheumdis-2023-eular.3450 Frei zugänglicher VolltextQuelle: OpenAlex

Rituximab use may indicate impaired quality of life in granulomatosis with polyangiitis

Ulusal Romatoloji Dergisi, 2023

DOI 10.4274/raed.galenos.2023.59244 Frei zugänglicher VolltextQuelle: OpenAlex

Evaluation of adult immunoglobulin A vasculitis with oxidative stress and inflammation biomarkers

Medicine Science | International Medical Journal, 2023

DOI 10.5455/medscience.2023.06.091 Frei zugänglicher VolltextQuelle: OpenAlex

Ulusal dev hücreli arterit veritabanı izlem verisi: Relaps oranı kontrollü çalışmalardan düşüktür.

Kocaeli Üniversitesi - AVESİS, 2023

Quelle: OpenAlex

Takayasu arteritine eşlik eden spondiloartrit spektrumundaki hastalıkların sıklığı ve hastalık seyrine etkisi.

Kocaeli Üniversitesi - AVESİS, 2023

Quelle: OpenAlex

IgA vaskülitinin çocuk ve erişkinlerde karşılaştırılması: Çok merkezli çalışma.

Kocaeli Üniversitesi - AVESİS, 2023

Quelle: OpenAlex

Spondiloartropati hastalarında secukinumab ve sertolizumab tedavilerin karşılaştırılması

AYBU AVESIS, 2023

Quelle: OpenAlex

An evaluation of the results of convalescent plasma therapy applied to pregnant womendiagnosed as COVID-19- positive in a pandemic center: A prospective cohort study

TURKISH JOURNAL OF MEDICAL SCIENCES, 2022

DOI 10.55730/1300-0144.5346 PMID 36326345 3 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

Hydroxychloroquine shortened hospital stay and reduced intensive care unit admissions in hospitalized COVID-19 patients

The Journal of Infection in Developing Countries, 2022

DOI 10.3855/jidc.14933 PMID 35192518 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

Secukinumab in the treatment of psoriatic arthritis or ankylosing spondyloarthritis with multiple sclerosis: a case series with literature review

Immunotherapy, 2022

DOI 10.2217/imt-2021-0128 PMID 35152720 11 Zitationen (Europe PMC) Quelle: Europe PMC

Clinical course of idiopathic inflammatory myopathies in COVID-19 pandemic: a single-center experience

Future virology, 2022

DOI 10.2217/fvl-2021-0146 PMID 35747325 3 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: Europe PMC

Effects of anti-SARS-CoV-2 vaccination on safety and disease exacerbation in patients with Behçet syndrome in a monocentric cohort

International journal of rheumatic diseases, 2022

DOI 10.1111/1756-185x.14387 PMID 35851753 10 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: Europe PMC